Endocultivation: Does delayed application of BMP improve intramuscular heterotopic bone formation?

Journal of Cranio-Maxillofacial Surgery

Volumn 38, Issue 1, 2010, Pages 54-59

  Warnke, Patrick H ^a,b   Bolte, Hendrik ^c   Schünemann, Kristina ^a   Nitsche, Tobias ^a   Sivananthan, Sureshan ^d   Sherry, Eugene ^b   Douglas, Timothy ^a   Wiltfang, Jörg ^a   Becker, Stephan T ^a  

^a UNIVERSITY OF KIEL   (Germany)

^b BOND UNIVERSITY   (Australia)

^c UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^d UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

application; BioOss; BMP 2; bone induction; endocultivation; heterotopic; scaffold; tissue engineering

Indexed keywords

BONE MORPHOGENETIC PROTEIN; FLUORESCENT DYE; HYDROXYAPATITE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE DENSITY; BONE REGENERATION; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; IMPLANTATION; LATISSIMUS DORSI MUSCLE; NONHUMAN; OSSIFICATION; RAT; SOFT TISSUE; TISSUE ENGINEERING; TISSUE GROWTH;

ANIMALS; BONE DENSITY; BONE MATRIX; BONE MORPHOGENETIC PROTEIN 2; CATTLE; IMPLANTS, EXPERIMENTAL; INFUSION PUMPS, IMPLANTABLE; MINERALS; MUSCLE, SKELETAL; OSTEOGENESIS; RATS; RATS, INBRED LEW; TIME FACTORS; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 74749089647     PISSN: 10105182     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcms.2009.09.002     Document Type: Article

References (22)

1. Bauer T.W. Bone graft substitutes. Skeletal Radiol 36 (2007) 1105-1107
2. Betz O.B., Betz V.M., Nazarian A., Egermann M., Gerstenfeld L.C., Einhorn T.A., Vrahas M.S., Bouxsein M.L., and Evans C.H. Delayed administration of adenoviral BMP-2 vector improves the formation of bone in osseous defects. Gene Ther 14 (2007) 1039-1044
3. Chung Y.I., Tae G., and Hong Y.S. A facile method to prepare heparin-functionalized nanoparticles for controlled release of growth factors. Biomaterials 27 (2006) 2621-2626
4. Gautschi O.P., Frey S.P., and Zellweger R. Bone morphogenetic proteins in clinical applications. ANZ J Surg 77 (2007) 626-631
5. Hollinger J.O., Uludag H., and Winn S.R. Sustained release emphasizing recombinant human bone morphogenetic protein-2. Adv Drug Deliv Rev 31 (1998) 303-318
6. Hu Z., Peel S.A., Ho S.K., Sandor G.K., and Clokie C.M. Role of bovine bone morphogenetic proteins in bone matrix protein and osteoblast-related gene expression during rat bone marrow stromal cell differentiation. J Craniofac Surg 16 (2005) 1006-1014
7. Issa J.P., Bentley M.V., Iyomasa M.M., Sebald W., and De Albuquerque R.F. Sustained release carriers used to delivery bone morphogenetic proteins in the bone healing process. Anat Histol Embryol 37 (2008) 181-187
8. Karageorgiou V., Tomkins M., Fajardo R., Meinel L., Snyder B., Wade K., Chen J., Vunjak-Novakovic G., and Kaplan D.L. Porous silk fibroin 3-D scaffolds for delivery of bone morphogenetic protein-2 in vitro and in vivo. J Biomed Mater Res A 78 (2006) 324-334
9. Kim H.D., and Valentini R.F. Retention and activity of BMP-2 in hyaluronic acid-based scaffolds in vitro. J Biomed Mater Res 59 (2002) 573-584
10. Lu L., Stamatas G.N., and Mikos A.G. Controlled release of transforming growth factor beta1 from biodegradable polymer microparticles. J Biomed Mater Res 50 (2000) 440-451
11. Nakagawa T., Sugiyama T., Kamei T., Murata T., and Tagawa T. An immuno-light- and electron-microscopic study of the expression of bone morphogenetic protein-2 during the process of ectopic bone formation in the rat. Arch Oral Biol 46 (2001) 403-411
12. Ruhe P.Q., Hedberg E.L., Padron N.T., Spauwen P.H., Jansen J.A., and Mikos A.G. rhBMP-2 release from injectable poly (DL-lactic-co-glycolic acid)/calcium-phosphate cement composites. J Bone Joint Surg Am 85-A Suppl 3 (2003) 75-81
13. Saito N., Okada T., Horiuchi H., Ota H., Takahashi J., Murakami N., Nawata M., Kojima S., Nozaki K., and Takaoka K. Local bone formation by injection of recombinant human bone morphogenetic protein-2 contained in polymer carriers. Bone 32 (2003) 381-386
14. Sebaoun J.D., Kantarci A., Turner J.W., Carvalho R.S., Van Dyke T.E., and Ferguson D.J. Modeling of trabecular bone and lamina dura following selective alveolar decortication in rats. J Periodontol 79 (2008) 1679-1688
15. Seeherman H., Li R., Bouxsein M., Kim H., Li X.J., Smith-Adaline E.A., Aiolova M., and Wozney J.M. rhBMP-2/calcium phosphate matrix accelerates osteotomy-site healing in a nonhuman primate model at multiple treatment times and concentrations. J Bone Joint Surg Am 88 (2006) 144-160
16. Springer I.N., Acil Y., Kuchenbecker S., Bolte H., Warnke P.H., Abboud M., Wiltfang J., and Terheyden H. Bone graft versus BMP-7 in a critical size defect-cranioplasty in a growing infant model. Bone 37 (2005) 563-569
17. Terheyden H., Knak C., Jepsen S., Palmie S., and Rueger D.R. Mandibular reconstruction with a prefabricated vascularized bone graft using recombinant human osteogenic protein-1: an experimental study in miniature pigs. Part I: prefabrication. Int J Oral Maxillofac Surg 30 (2001) 373-379
18. Vehof J.W., Takita H., Kuboki Y., Spauwen P.H., and Jansen J.A. Histological characterization of the early stages of bone morphogenetic protein-induced osteogenesis. J Biomed Mater Res 61 (2002) 440-449
19. Warnke P.H., Springer I.N., Acil Y., Julga G., Wiltfang J., Ludwig K., Russo P.A., Sherry E., Sivananthan S., Hedderich J., and Terheyden H. The mechanical integrity of in vivo engineered heterotopic bone. Biomaterials 27 (2006) 1081-1087
20. Warnke P.H., Springer I.N., Wiltfang J., Acil Y., Eufinger H., Wehmoller M., Russo P.A., Bolte H., Sherry E., Behrens E., and Terheyden H. Growth and transplantation of a custom vascularised bone graft in a man. Lancet 364 (2004) 766-770
21. Warnke P.H., Wiltfang J., Springer I., Acil Y., Bolte H., Kosmahl M., Russo P.A., Sherry E., Lutzen U., Wolfart S., and Terheyden H. Man as living bioreactor: fate of an exogenously prepared customized tissue-engineered mandible. Biomaterials 27 (2006) 3163-3167
22. Woo B.H., Fink B.F., Page R., Schrier J.A., Jo Y.W., Jiang G., DeLuca M., Vasconez H.C., and DeLuca P.P. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res 18 (2001) 1747-1753